Sabine Hombach-Klonisch

Human medullary thyroid carcinoma: a source and potential target for relaxin-like hormones.

Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells.

INSL3 in the benign hyperplastic and neoplastic human prostate gland.

The roe deer as a model for studying seasonal regulation of testis function.

Dioxin exerts anti-estrogenic actions in a novel dioxin-responsive telomerase-immortalized epithelial cell line of the porcine oviduct (TERT-OPEC).

Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness.

A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis.

Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications.

Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

Cancer stem cell markers in common cancers - therapeutic implications.

INSL3 has tumor-promoting activity in thyroid cancer.

Thyroid stem cells and cancer.

Nuclear imaging in three dimensions: a unique tool in cancer research.

Estrogen-independent actions of environmentally relevant AhR-agonists in human endometrial epithelial cells.

INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours.

Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction.

Peri-conceptional changes in maternal exposure to sewage sludge chemicals disturbs fetal thyroid gland development in sheep.

HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.

Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development.

Three-dimensional telomere dynamics in follicular thyroid cancer.

C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells.

Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.

Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.

Gesture-controlled interactive three dimensional anatomy: a novel teaching tool in head and neck surgery.

Platinum (IV) coiled coil nanotubes selectively kill human glioblastoma cells.

RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.

RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer.

High Mobility Group A2 protects cancer cells against telomere dysfunction.

Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA).

Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.

Population-based analysis of breast cancer treatment by intrinsic sub-type in Manitoba, Canada.

Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.

Dovitinib enhances temozolomide efficacy in glioblastoma cells.

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.

Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells.

C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.

HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells.

Maternal smoking and high BMI disrupt thyroid gland development.

Statins: a new approach to combat temozolomide chemoresistance in glioblastoma.

A radial microfluidic platform for higher throughput chemotaxis studies with individual gradient control.

Claudin 1 Is Highly Upregulated by PKC in MCF7 Human Breast Cancer Cells and Correlates Positively with PKCε in Patient Biopsies.

Unlocking bone for proteomic analysis and FISH.

Emerging roles for the relaxin/RXFP1 system in cancer therapy.

Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.

Modulation of Wnt/β-catenin signaling promotes blood-brain barrier phenotype in cultured brain endothelial cells.

Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells.

Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.

The Breast Tumor Microenvironment: A Key Player in Metastatic Spread.

Brain Microvascular Pericytes-More than Bystanders in Breast Cancer Brain Metastasis.

Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling.

Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment.

Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer.

DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases.

Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment.

Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome.

Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis.

C1QTNF Related protein 8 (CTRP8) is a marker of myeloid derived innate immune cell populations in the human breast cancer microenvironment.